NCT00045305 2023-06-28Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesEastern Cooperative Oncology GroupPhase 2 Completed17 enrolled 10 charts
NCT01168219 2022-08-04Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Completed68 enrolled 11 charts
NCT01789255 2018-07-24Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesNational Cancer Institute (NCI)Phase 2 Completed12 enrolled 11 charts